IBDEI07R ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10236,0)
 ;;=379.21^^52^594^104
 ;;^UTILITY(U,$J,358.3,10236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10236,1,3,0)
 ;;=3^Vitreous Detachment/Degeneration (Pvd)
 ;;^UTILITY(U,$J,358.3,10236,1,4,0)
 ;;=4^379.21
 ;;^UTILITY(U,$J,358.3,10236,2)
 ;;=Vitreous Detachment/Degeneration^88242
 ;;^UTILITY(U,$J,358.3,10237,0)
 ;;=379.24^^52^594^105
 ;;^UTILITY(U,$J,358.3,10237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10237,1,3,0)
 ;;=3^Vitreous Floaters
 ;;^UTILITY(U,$J,358.3,10237,1,4,0)
 ;;=4^379.24
 ;;^UTILITY(U,$J,358.3,10237,2)
 ;;=Vitreous Floaters^88242
 ;;^UTILITY(U,$J,358.3,10238,0)
 ;;=379.26^^52^594^107
 ;;^UTILITY(U,$J,358.3,10238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10238,1,3,0)
 ;;=3^Vitreous Prolapse
 ;;^UTILITY(U,$J,358.3,10238,1,4,0)
 ;;=4^379.26
 ;;^UTILITY(U,$J,358.3,10238,2)
 ;;=Vitreous Prolapse^269312
 ;;^UTILITY(U,$J,358.3,10239,0)
 ;;=379.23^^52^594^106
 ;;^UTILITY(U,$J,358.3,10239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10239,1,3,0)
 ;;=3^Vitreous Hemorrhage
 ;;^UTILITY(U,$J,358.3,10239,1,4,0)
 ;;=4^379.23
 ;;^UTILITY(U,$J,358.3,10239,2)
 ;;=Vitreous Hemorrhage^127096
 ;;^UTILITY(U,$J,358.3,10240,0)
 ;;=362.18^^52^594^89
 ;;^UTILITY(U,$J,358.3,10240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10240,1,3,0)
 ;;=3^Retinal Vasculitis
 ;;^UTILITY(U,$J,358.3,10240,1,4,0)
 ;;=4^362.18
 ;;^UTILITY(U,$J,358.3,10240,2)
 ;;=Retinal Vasculitis^264463
 ;;^UTILITY(U,$J,358.3,10241,0)
 ;;=360.21^^52^594^31
 ;;^UTILITY(U,$J,358.3,10241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10241,1,3,0)
 ;;=3^Degenerative Myopia
 ;;^UTILITY(U,$J,358.3,10241,1,4,0)
 ;;=4^360.21
 ;;^UTILITY(U,$J,358.3,10241,2)
 ;;=Degenerative Myopia^268553
 ;;^UTILITY(U,$J,358.3,10242,0)
 ;;=362.64^^52^594^80
 ;;^UTILITY(U,$J,358.3,10242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10242,1,3,0)
 ;;=3^Reticular Degeneration
 ;;^UTILITY(U,$J,358.3,10242,1,4,0)
 ;;=4^362.64
 ;;^UTILITY(U,$J,358.3,10242,2)
 ;;=Reticular Degeneration^268645
 ;;^UTILITY(U,$J,358.3,10243,0)
 ;;=362.61^^52^594^29
 ;;^UTILITY(U,$J,358.3,10243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10243,1,3,0)
 ;;=3^Degeneration, Paving Stone
 ;;^UTILITY(U,$J,358.3,10243,1,4,0)
 ;;=4^362.61
 ;;^UTILITY(U,$J,358.3,10243,2)
 ;;=Paving Stone Degeneration^268642
 ;;^UTILITY(U,$J,358.3,10244,0)
 ;;=362.42^^52^594^94
 ;;^UTILITY(U,$J,358.3,10244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10244,1,3,0)
 ;;=3^Rpe Detachment, Serous
 ;;^UTILITY(U,$J,358.3,10244,1,4,0)
 ;;=4^362.42
 ;;^UTILITY(U,$J,358.3,10244,2)
 ;;=Serous RPE Detachment^268633
 ;;^UTILITY(U,$J,358.3,10245,0)
 ;;=362.43^^52^594^93
 ;;^UTILITY(U,$J,358.3,10245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10245,1,3,0)
 ;;=3^Rpe Detachment, Hemorrhagic
 ;;^UTILITY(U,$J,358.3,10245,1,4,0)
 ;;=4^362.43
 ;;^UTILITY(U,$J,358.3,10245,2)
 ;;=Hemorrhagic RPE Detachment^268634
 ;;^UTILITY(U,$J,358.3,10246,0)
 ;;=250.00^^52^594^34
 ;;^UTILITY(U,$J,358.3,10246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10246,1,3,0)
 ;;=3^Dm Type II, No Retinopathy
 ;;^UTILITY(U,$J,358.3,10246,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,10246,2)
 ;;=DM Type II, No Retinopathy^33605
 ;;^UTILITY(U,$J,358.3,10247,0)
 ;;=250.01^^52^594^33
 ;;^UTILITY(U,$J,358.3,10247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10247,1,3,0)
 ;;=3^Dm Type I, No Retinopathy
 ;;^UTILITY(U,$J,358.3,10247,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,10247,2)
 ;;=DM Type I, No Retinopathy^33586
 ;;^UTILITY(U,$J,358.3,10248,0)
 ;;=250.50^^52^594^25
 ;;^UTILITY(U,$J,358.3,10248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10248,1,3,0)
 ;;=3^Csme In DM Type II
 ;;^UTILITY(U,$J,358.3,10248,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,10248,2)
 ;;=CSME in DM type II^267839^362.83
 ;;^UTILITY(U,$J,358.3,10249,0)
 ;;=250.51^^52^594^27
 ;;^UTILITY(U,$J,358.3,10249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10249,1,3,0)
 ;;=3^DM Type I w/ Ophtharlmic Manifestation
 ;;^UTILITY(U,$J,358.3,10249,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,10249,2)
 ;;=CSME in DM Type I^267840^362.83
 ;;^UTILITY(U,$J,358.3,10250,0)
 ;;=362.01^^52^594^32
 ;;^UTILITY(U,$J,358.3,10250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10250,1,3,0)
 ;;=3^Diabetic Retinopathy Nos
 ;;^UTILITY(U,$J,358.3,10250,1,4,0)
 ;;=4^362.01
 ;;^UTILITY(U,$J,358.3,10250,2)
 ;;=^12257
 ;;^UTILITY(U,$J,358.3,10251,0)
 ;;=362.02^^52^594^72
 ;;^UTILITY(U,$J,358.3,10251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10251,1,3,0)
 ;;=3^Prolif Diab Retinopathy
 ;;^UTILITY(U,$J,358.3,10251,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,10251,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,10252,0)
 ;;=362.03^^52^594^64
 ;;^UTILITY(U,$J,358.3,10252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10252,1,3,0)
 ;;=3^Nonprolf Db Retnoph Nos
 ;;^UTILITY(U,$J,358.3,10252,1,4,0)
 ;;=4^362.03
 ;;^UTILITY(U,$J,358.3,10252,2)
 ;;=^332786
 ;;^UTILITY(U,$J,358.3,10253,0)
 ;;=362.04^^52^594^61
 ;;^UTILITY(U,$J,358.3,10253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10253,1,3,0)
 ;;=3^Mild Nonprolf Db Retnoph
 ;;^UTILITY(U,$J,358.3,10253,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,10253,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,10254,0)
 ;;=362.05^^52^594^62
 ;;^UTILITY(U,$J,358.3,10254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10254,1,3,0)
 ;;=3^Mod Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,10254,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,10254,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,10255,0)
 ;;=362.06^^52^594^98
 ;;^UTILITY(U,$J,358.3,10255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10255,1,3,0)
 ;;=3^Sev Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,10255,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,10255,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,10256,0)
 ;;=379.27^^52^594^103
 ;;^UTILITY(U,$J,358.3,10256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10256,1,3,0)
 ;;=3^Vitreomacular Adhesion
 ;;^UTILITY(U,$J,358.3,10256,1,4,0)
 ;;=4^379.27
 ;;^UTILITY(U,$J,358.3,10256,2)
 ;;=^340517
 ;;^UTILITY(U,$J,358.3,10257,0)
 ;;=115.02^^52^594^44
 ;;^UTILITY(U,$J,358.3,10257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10257,1,3,0)
 ;;=3^Histoplasma Capsulatum Retinitis
 ;;^UTILITY(U,$J,358.3,10257,1,4,0)
 ;;=4^115.02
 ;;^UTILITY(U,$J,358.3,10257,2)
 ;;=^266890
 ;;^UTILITY(U,$J,358.3,10258,0)
 ;;=190.5^^52^594^58
 ;;^UTILITY(U,$J,358.3,10258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10258,1,3,0)
 ;;=3^Malig Retina
 ;;^UTILITY(U,$J,358.3,10258,1,4,0)
 ;;=4^190.5
 ;;^UTILITY(U,$J,358.3,10258,2)
 ;;=^73530
 ;;^UTILITY(U,$J,358.3,10259,0)
 ;;=198.4^^52^594^59
 ;;^UTILITY(U,$J,358.3,10259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10259,1,3,0)
 ;;=3^Malig Secondary Choroid
 ;;^UTILITY(U,$J,358.3,10259,1,4,0)
 ;;=4^198.4
 ;;^UTILITY(U,$J,358.3,10259,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,10260,0)
 ;;=200.00^^52^594^81
 ;;^UTILITY(U,$J,358.3,10260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10260,1,3,0)
 ;;=3^Reticulosarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,10260,1,4,0)
 ;;=4^200.00
 ;;^UTILITY(U,$J,358.3,10260,2)
 ;;=^72635
 ;;^UTILITY(U,$J,358.3,10261,0)
 ;;=228.03^^52^594^38
 ;;^UTILITY(U,$J,358.3,10261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10261,1,3,0)
 ;;=3^Hemangioma Retina
 ;;^UTILITY(U,$J,358.3,10261,1,4,0)
 ;;=4^228.03
 ;;^UTILITY(U,$J,358.3,10261,2)
 ;;=^267700
 ;;^UTILITY(U,$J,358.3,10262,0)
 ;;=228.09^^52^594^39
 ;;^UTILITY(U,$J,358.3,10262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10262,1,3,0)
 ;;=3^Hemangioma,Oth Sites
 ;;^UTILITY(U,$J,358.3,10262,1,4,0)
 ;;=4^228.09
 ;;^UTILITY(U,$J,358.3,10262,2)
 ;;=^55270
 ;;^UTILITY(U,$J,358.3,10263,0)
 ;;=360.00^^52^594^73
 ;;^UTILITY(U,$J,358.3,10263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10263,1,3,0)
 ;;=3^Purulent Endophthalmitis,Unspec
 ;;^UTILITY(U,$J,358.3,10263,1,4,0)
 ;;=4^360.00
 ;;^UTILITY(U,$J,358.3,10263,2)
 ;;=^40605
 ;;^UTILITY(U,$J,358.3,10264,0)
 ;;=360.03^^52^594^21
 ;;^UTILITY(U,$J,358.3,10264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10264,1,3,0)
 ;;=3^Chronic Endophthalmitis
 ;;^UTILITY(U,$J,358.3,10264,1,4,0)
 ;;=4^360.03
 ;;^UTILITY(U,$J,358.3,10264,2)
 ;;=^268547
 ;;^UTILITY(U,$J,358.3,10265,0)
 ;;=361.02^^52^594^76
 ;;^UTILITY(U,$J,358.3,10265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10265,1,3,0)
 ;;=3^Recent RD w/ Multiple Defects
 ;;^UTILITY(U,$J,358.3,10265,1,4,0)
 ;;=4^361.02
 ;;^UTILITY(U,$J,358.3,10265,2)
 ;;=^268587
 ;;^UTILITY(U,$J,358.3,10266,0)
 ;;=361.03^^52^594^75
 ;;^UTILITY(U,$J,358.3,10266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10266,1,3,0)
 ;;=3^Recent RD w/ Giant Tear
 ;;^UTILITY(U,$J,358.3,10266,1,4,0)
 ;;=4^361.03
 ;;^UTILITY(U,$J,358.3,10266,2)
 ;;=^268588
 ;;^UTILITY(U,$J,358.3,10267,0)
 ;;=361.04^^52^594^79
 ;;^UTILITY(U,$J,358.3,10267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10267,1,3,0)
 ;;=3^Ret Det,Partial w/ Dialysis
 ;;^UTILITY(U,$J,358.3,10267,1,4,0)
 ;;=4^361.04
 ;;^UTILITY(U,$J,358.3,10267,2)
 ;;=^268589
 ;;^UTILITY(U,$J,358.3,10268,0)
 ;;=361.12^^52^594^8
 ;;^UTILITY(U,$J,358.3,10268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10268,1,3,0)
 ;;=3^Bullous Retinoschisis
 ;;^UTILITY(U,$J,358.3,10268,1,4,0)
 ;;=4^361.12
 ;;^UTILITY(U,$J,358.3,10268,2)
 ;;=^268596
 ;;^UTILITY(U,$J,358.3,10269,0)
 ;;=361.2^^52^594^102
 ;;^UTILITY(U,$J,358.3,10269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10269,1,3,0)
 ;;=3^Uveal Effusion/SRD
 ;;^UTILITY(U,$J,358.3,10269,1,4,0)
 ;;=4^361.2
 ;;^UTILITY(U,$J,358.3,10269,2)
 ;;=^268601
 ;;^UTILITY(U,$J,358.3,10270,0)
 ;;=361.9^^52^594^83
 ;;^UTILITY(U,$J,358.3,10270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10270,1,3,0)
 ;;=3^Retinal Detachment NOS
 ;;^UTILITY(U,$J,358.3,10270,1,4,0)
 ;;=4^361.9
 ;;^UTILITY(U,$J,358.3,10270,2)
 ;;=^105529
 ;;^UTILITY(U,$J,358.3,10271,0)
 ;;=362.10^^52^594^95
 ;;^UTILITY(U,$J,358.3,10271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10271,1,3,0)
 ;;=3^Rubella Retinopathy
 ;;^UTILITY(U,$J,358.3,10271,1,4,0)
 ;;=4^362.10
